.Welcome to recently's Chutes & Ladders, our summary of considerable leadership hirings, shooting...
.Adhering to an inadequate presenting for Lykos Therapeutics' MDMA prospect for post-traumatic stres...
.AN2 Therapies is actually reviewing its own service in feedback to lackluster midphase data, sweari...
.Merck & Co. is actually paying $700 million upfront to challenge Amgen in a blood cancer market....
.With Gilead Sciences on the verge of an FDA choice for its liver disease drug seladelpar, the compa...
.Chief executive officer David Ricks may observe the companies establishing outdoors tents at baseca...
.Cushion Liquidators has transformed Entero Therapeutics white colored as a piece. The financial ins...
.Exelixis is surrendering on its own cells element (TF)- targeting antibody-drug conjugate after wra...
.3 weeks after Roche's Genentech unit walked away from an SHP2 inhibitor contract, Relay Therapy has...
.Stoke Therapies' Dravet disorder medicine has actually been freed from a predisposed grip, getting ...